Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - chondroitini sulfas natricus - kapsel - chondroitini sulfas natricus 400 mg, magnesii stearas, materiale di capsula: gelatina, e 104, e 132, pro capsula corresp. natrium 36.6 mg. - antiartrosico - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - chondroitini sulfas natricus - granulato in bustine - chondroitini sulfas natricus 400 mg, acidum citricum, silica colloidalis anhydrica, sorbitolum 1.12 g, saccharinum natricum, aromatica (arancia), e 320, e 160(a), saccharum q.s., e 301, e 307, ad granulatum, pro charta 1.8 g corresp. natrium 38 mg. - antiartrosico - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - chondroitini sulfas natricus - granulato in bustine - chondroitini sulfas natricus 800 mg, acidum citricum, silica colloidalis anhydrica, sorbitolum 2.24 g, saccharinum natricum, aromatica (arancia), e 320, e 160(a), saccharum q.s., e 301, e 307, ad granulatum, pro charta 3.6 g corresp. natrium 76 mg. - antiartrosico - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - chondroitini sulfas natricus - compresse - chondroitini sulfas natricus 800 mg, magnesii stearas, pro compresso corresp. natrium 73.1 mg. - antiartrosico - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - chondroitini sulfas natricus - compresse - chondroitini sulfas natricus 400 mg, magnesii stearas, pro compresso corresp. natrium 36.6 mg. - antiartrosico - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

pierre fabre pharma sa - chondroitini sulfas natricus - kapseln - chondroitini sulfas natricus 500 mg, talcum, kapselhülle: gelatina q.s., e 132, e 171, pro capsula corresp. natrium 45 mg. - arthrosen - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - chondroitini sulfas natricus - gel-orale in bustine - chondroitini sulfas natricus 400 mg, xylitolum, cellulosum microcristallinum, aqua, aromatica (vaniglia), ethanolum q.s., aromatica (caramello), e 202, e 211 3 mg, ad gelatum, pro charta, natrium 37 mg. - antiartrosico - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - chondroitini sulfas natricus - gel-orale in bustine - chondroitini sulfas natricus 800 mg, xylitolum, cellulosum microcristallinum, aqua, aromatica (vaniglia), aromatica (caramello), e 202, e 211 6 mg, ad gelatum, pro charta corresp. natrium 74 mg. - antiartrosico - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - glucosamini hydrochloridum, chondroitini sulfas natricus - hartkapseln - glucosamini hydrochloridum 250 mg, chondroitini sulfas natricus 200 mg corresp. natrium 18 mg, magnesii stearas, materiale di capsula: gelatina, e 132, e 171, pro capsula. - antiartrosico - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

medinova ag - heparinoidum (chondroitini polysulfas) - creme - heparinoidum (chondroitini polysulfas) 3 mg, corresp. 250 u., glycerolum (85 per centum), acidum stearicum, alcoholes adipis lanae, alcohol cetylicus et stearylicus 31.375 mg, vaselinum album, alcohol myristylicus, alcohol isopropylicus, kalii hydroxidum, e 218 1.6 mg, thymolum, propylis parahydroxybenzoas 0.4 mg, aqua purificata, ad unguentum pro 1 g. - venenmittel für den äusserlichen gebrauch - synthetika